A drug administered to a patient for treatment, listed in SEER*Rx as a chemotherapeutic, hormonal or immunotherapy agent should be coded under chemotherapy [#1390], hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s) listed in SEER*Rx for that agent. Do not code under the data item, Other Therapy [NAACCR #1420]. Refer to the 2026 SEER manual for more information.
- Drugs (1805)
- Regimen (458)
- Show Entries
| Name | Primary Site |
|---|---|
| SIMAL-bone marrow transplant | |
| SIMAL-pilot | |
| SIMAL-second induction/maintenance | |
| SK | |
| SMF | |
| SMILE | Extranodal natural killer/T-cell lymphoma, nasal type (ENKL) |
| STEAM | |
| SWOG CMFVP | |
| Stanford V | |
| T-10 protocol | |
| T-2 protocol | |
| T-CAP | |
| T-CID | |
| T-MOP | |
| TAC | |
| TAD | |
| TAXOL/CBDCA | |
| TBP | |
| TCHP | Breast |
| TEE | |
| TEMP | |
| THP | Breast |
| TIC | |
| TIP | |
| TIT |
Home